These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
942 related articles for article (PubMed ID: 15935057)
1. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. Peng S; Wuu J; Mufson EJ; Fahnestock M J Neurochem; 2005 Jun; 93(6):1412-21. PubMed ID: 15935057 [TBL] [Abstract][Full Text] [Related]
2. Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease. Michalski B; Fahnestock M Brain Res Mol Brain Res; 2003 Mar; 111(1-2):148-54. PubMed ID: 12654514 [TBL] [Abstract][Full Text] [Related]
3. Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms. Lee J; Fukumoto H; Orne J; Klucken J; Raju S; Vanderburg CR; Irizarry MC; Hyman BT; Ingelsson M Exp Neurol; 2005 Jul; 194(1):91-6. PubMed ID: 15899246 [TBL] [Abstract][Full Text] [Related]
4. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Fahnestock M; Michalski B; Xu B; Coughlin MD Mol Cell Neurosci; 2001 Aug; 18(2):210-20. PubMed ID: 11520181 [TBL] [Abstract][Full Text] [Related]
5. Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease. Ikonomovic MD; Mufson EJ; Wuu J; Bennett DA; DeKosky ST Arch Neurol; 2005 Mar; 62(3):425-30. PubMed ID: 15767507 [TBL] [Abstract][Full Text] [Related]
6. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease. Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028 [TBL] [Abstract][Full Text] [Related]
7. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. Gilmor ML; Erickson JD; Varoqui H; Hersh LB; Bennett DA; Cochran EJ; Mufson EJ; Levey AI J Comp Neurol; 1999 Sep; 411(4):693-704. PubMed ID: 10421878 [TBL] [Abstract][Full Text] [Related]
8. Quantitative EEG in progressing vs stable mild cognitive impairment (MCI): results of a 1-year follow-up study. Luckhaus C; Grass-Kapanke B; Blaeser I; Ihl R; Supprian T; Winterer G; Zielasek J; Brinkmeyer J Int J Geriatr Psychiatry; 2008 Nov; 23(11):1148-55. PubMed ID: 18537220 [TBL] [Abstract][Full Text] [Related]
9. NT-3 modulates BDNF and proBDNF levels in naïve and kindled rat hippocampus. Ullal GR; Michalski B; Xu B; Racine RJ; Fahnestock M Neurochem Int; 2007 May; 50(6):866-71. PubMed ID: 17462792 [TBL] [Abstract][Full Text] [Related]
10. Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease. Mufson EJ; Ikonomovic MD; Styren SD; Counts SE; Wuu J; Leurgans S; Bennett DA; Cochran EJ; DeKosky ST Arch Neurol; 2003 Aug; 60(8):1143-8. PubMed ID: 12925373 [TBL] [Abstract][Full Text] [Related]
11. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Keller JN; Schmitt FA; Scheff SW; Ding Q; Chen Q; Butterfield DA; Markesbery WR Neurology; 2005 Apr; 64(7):1152-6. PubMed ID: 15824339 [TBL] [Abstract][Full Text] [Related]
12. The cholinergic system in aging and neuronal degeneration. Schliebs R; Arendt T Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918 [TBL] [Abstract][Full Text] [Related]
13. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Markesbery WR; Kryscio RJ; Lovell MA; Morrow JD Ann Neurol; 2005 Nov; 58(5):730-5. PubMed ID: 16240347 [TBL] [Abstract][Full Text] [Related]
14. Amyloid-beta at sublethal level impairs BDNF-induced arc expression in cortical neurons. Wang DC; Chen SS; Lee YC; Chen TJ Neurosci Lett; 2006 May; 398(1-2):78-82. PubMed ID: 16412575 [TBL] [Abstract][Full Text] [Related]
15. Synaptic degeneration in Alzheimer's disease. Arendt T Acta Neuropathol; 2009 Jul; 118(1):167-79. PubMed ID: 19390859 [TBL] [Abstract][Full Text] [Related]
17. Altered NCAM expression associated with the cholinergic system in Alzheimer's disease. Aisa B; Gil-Bea FJ; Solas M; García-Alloza M; Chen CP; Lai MK; Francis PT; Ramírez MJ J Alzheimers Dis; 2010; 20(2):659-68. PubMed ID: 20164549 [TBL] [Abstract][Full Text] [Related]
18. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients. Hernanz A; De la Fuente M; Navarro M; Frank A Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509 [TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor facilitates TrkB down-regulation and neuronal injury after status epilepticus in the rat hippocampus. Unsain N; Montroull LE; Mascó DH J Neurochem; 2009 Oct; 111(2):428-40. PubMed ID: 19686240 [TBL] [Abstract][Full Text] [Related]
20. Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease. Hashimoto R; Hirata Y; Asada T; Yamashita F; Nemoto K; Mori T; Moriguchi Y; Kunugi H; Arima K; Ohnishi T Genes Brain Behav; 2009 Feb; 8(1):43-52. PubMed ID: 18786162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]